✦ LIBER ✦

Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases

✍ Scribed by Halilbasic, Emina; Baghdasaryan, Anna; Trauner, Michael

Book ID: 120080696
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 404 KB
Volume: 17
Category: Article
ISSN: 1089-3261
DOI: 10.1016/j.cld.2012.12.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nuclear receptors as therapeutic targets

Nuclear receptors as therapeutic targets in cholestatic liver diseases

✍ Gernot Zollner; Michael Trauner 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 373 KB

Nuclear Receptors CAR and PXR; therapeut

Nuclear Receptors CAR and PXR; therapeutic targets for cholestatic liver disease

✍ Kakizaki, Satoru 📂 Article 📅 2011 🏛 Frontiers in BioScience 🌐 English ⚖ 433 KB

Nuclear receptor ligands in therapy of c

Nuclear receptor ligands in therapy of cholestatic liver disease

✍ Sturm, Ekkehard 📂 Article 📅 2009 🏛 Frontiers in BioScience 🌐 English ⚖ 349 KB

Nuclear receptors as drug targets in met

Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy

✍ James F. Tobin; Leonard P. Freedman 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Nuclear receptors as drug targets for me

Nuclear receptors as drug targets for metabolic disease

✍ Ira G. Schulman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 390 KB

The nuclear bile acid receptor FXR as a

The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: Hype or hope?

✍ Michael Trauner 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 2 views

Farnesoid X receptor (FXR) is a bile acid-activated transcription factor that is a member of the nuclear hormone receptor superfamily. FXR-null mice exhibit a phenotype similar to Byler disease, an inherited cholestatic liver disorder. In the liver, activation of FXR induces transcription of transpo